Workshop: options for therapy in ovarian cancer.


Current and future options for sequential therapy for first and subsequent relapses in ovarian cancer were discussed in three workshops centered around a number of case studies. The participants included investigator oncologists from the USA, Europe, and Asia. For a platinum-resistant patient, topotecan or pegylated liposomal doxorubicin was considered the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.